Spectrometric Smartphone-Based System for Ibuprofen Quantification in Commercial Dosage Tablets

Please use this identifier to cite or link to this item: http://hdl.handle.net/10045/92507
Información del item - Informació de l'item - Item information
Title: Spectrometric Smartphone-Based System for Ibuprofen Quantification in Commercial Dosage Tablets
Authors: Aguirre Pastor, Miguel Ángel | Long, Kenneth D. | Cunningham, Brian T.
Research Group/s: Espectroscopía Atómica-Masas y Química Analítica en Condiciones Extremas
Center, Department or Service: Universidad de Alicante. Departamento de Química Analítica, Nutrición y Bromatología | Universidad de Alicante. Instituto Universitario de Materiales
Keywords: Analytical chemistry | Absorption spectroscopy | Image analysis | Regulatory science | Analysis
Knowledge Area: Química Analítica
Issue Date: 15-Mar-2019
Publisher: Elsevier
Citation: Journal of Pharmaceutical Sciences. 2019, 108(8): 2593-2598. doi:10.1016/j.xphs.2019.03.010
Abstract: A rapid and portable analytical methodology has been developed for ibuprofen (IBU) quantification in commercial dosage tablets using a spectrometric smartphone-based system. The analytical methodology employs point-of-use approaches both for sample preparation and detection, demonstrating its potential utility for portable quality control of pharmaceutical products. In this work, IBU is dissolved in methanol and then treated with a Co(II) aqueous solution, forming a blue complex which is extractable by dispersive liquid-liquid microextraction. Then, the sample’s absorption spectrum is directly measured by a spectrometric smartphone-based system using cartridge made of polyoxymethylene for solvent compatibility. The main experimental factors affecting the dispersive liquid-liquid microextraction of Co-IBU complex were optimized using a multivariate analysis. Under optimized conditions, a working range between 20 and 80 μg mL−1 was obtained with a correlation coefficient of 0.996 for 5 calibration points. The limit of detection and limit of quantification obtained were 4 and 12 μg mL−1, respectively. The performance of the proposed methodology was evaluated in commercial tablet dosage forms, and the results demonstrate the ability of the method to determine IBU in samples representative of those used in real-world quality control applications. Recovery values between 97% and 105% were obtained, which are comparable to those obtained via standard titrimetric methodology.
Sponsor: The authors would like to acknowledge the National Science Foundation for their support of this work via Grant no. CBET 12-64377. M.A.A. is grateful to Generalitat Valenciana (Spain) (APOSTD/2016/076) for his Post-Doctoral fellowship and the financial support from the European Social Fund (ESF). K.D.L. is supported by a Ruth L. Kirschstein Pre-Doctoral Fellowship (NIH F30AI122925).
URI: http://hdl.handle.net/10045/92507
ISSN: 0022-3549 (Print) | 1520-6017 (Online)
DOI: 10.1016/j.xphs.2019.03.010
Language: eng
Type: info:eu-repo/semantics/article
Rights: © 2019 Published by Elsevier Inc. on behalf of the American Pharmacists Association
Peer Review: si
Publisher version: https://doi.org/10.1016/j.xphs.2019.03.010
Appears in Collections:INV - SP-BG - Artículos de Revistas

Files in This Item:
Files in This Item:
File Description SizeFormat 
Thumbnail2019_Aguirre_etal_JPharmaceuticalSci_InPress.pdfIn Press (acceso restringido)807,19 kBAdobe PDFOpen    Request a copy


Items in RUA are protected by copyright, with all rights reserved, unless otherwise indicated.